Quoin Pharmaceuticals Ltd. (QNRX) — Institutional Holders, Q2 2026
19 institutional investment managers reported a QNRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $7.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
QNRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Stonepine Capital ManagementAdded · +712,086 sh+$3.4M
- MILLENNIUM MANAGEMENTAdded · +36,076 sh+$174.6K
- BARCLAYS PLCAdded · +20,169 sh+$97.6K
- AIGH Capital ManagementAdded · +19,000 sh+$92.0K
- Dauntless Investment GroupAdded · +18,395 sh+$89.0K
Biggest sellers
- Centiva CapitalSold out · -60,000 sh-$290.4K
- Velan Capital Investment ManagementTrimmed · -52,477 sh-$254.0K
- CITADEL ADVISORSSold out · -32,519 sh-$157.4K
- Woodline PartnersTrimmed · -3,136 sh-$15.2K
- GAMMA InvestingTrimmed · -1,281 sh-$6.2K
QNRX 13F holders ranked 1–19 of 19
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Stonepine Capital Management#1 · 765,546 sh | 765,546 | $2.0M | 0.96% | +1332.0% |
| 2 | Dauntless Investment Group#2 · 214,987 sh | 214,987 | $1.0M | 0.82% | +9.4% |
| 3 | Ikarian Capital#3 · 211,538 sh | 211,538 | $1.0M | 0.11% | 0.0% |
| 4 | MILLENNIUM MANAGEMENT#4 · 112,323 sh | 112,323 | $543.6K | <0.01% | +47.3% |
| 5 | SummitTX Capital, L.P.#5 · 100,300 sh | 100,300 | $485.5K | 0.01% | 0.0% |
| 6 | Woodline Partners#6 · 76,446 sh | 76,446 | $370.0K | <0.01% | -3.9% |
| 7 | abrdn plc#7 · 75,000 sh | 75,000 | $363.0K | <0.01% | 0.0% |
| 8 | Soleus Capital Management, L.P.#8 · 72,730 sh | 72,730 | $352.0K | 0.01% | 0.0% |
| 9 | AIGH Capital Management#9 · 70,000 sh | 70,000 | $338.8K | 0.02% | +37.3% |
| 10 | BOOTHBAY FUND MANAGEMENT#10 · 59,838 sh | 59,838 | $289.6K | <0.01% | 0.0% |
| 11 | Velan Capital Investment Management#11 · 32,372 sh | 32,372 | $156.7K | 0.10% | -61.8% |
| 12 | BARCLAYS PLC#12 · 21,469 sh | 21,469 | $103.9K | 0.00% | +1551.5% |
| 13 | Birchview Capital#13 · 20,000 sh | 20,000 | $96.8K | 0.05% | 0.0% |
| 14 | XTX Topco Ltd#14 · 15,006 sh | 15,006 | $72.6K | <0.01% | New |
| 15 | MORGAN STANLEY#15 · 8,000 sh | 8,000 | $38.7K | 0.00% | +100.0% |
| 16 | UBS Group AG#16 · 6,772 sh | 6,772 | $32.8K | 0.00% | +169.6% |
| 17 | RHUMBLINE ADVISERS#17 · 2,332 sh | 2,332 | $11.3K | 0.00% | +53.3% |
| 18 | GAMMA Investing#18 · 439 sh | 439 | $2.1K | — | -74.5% |
| 19 | SBI Securities , Ltd.#19 · 355 sh | 355 | $1.7K | — | New |
Funds that sold out of QNRX in Q2 2026 (3)
Held QNRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Centiva Capital60,000 sh | 60,000 | $396.0K |
| CITADEL ADVISORS32,519 sh | 32,519 | $214.6K |
| ROYAL BANK OF CANADA11 sh | 11 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.